Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
, 34 (1), 91-104

Pharmacological Therapies for Obesity

Affiliations
Review

Pharmacological Therapies for Obesity

Lee M Kaplan. Gastroenterol Clin North Am.

Abstract

Pharmacological therapy for obesity is in transition. Historically,there have been few effective agents, and many have been with-drawn because of unacceptable side effects. Current options include three medications approved by the FDA for the treatment of obesity: phentermine, sibutramine and orlistat. Phentermine and sibutramine suppress appetite and promote thermogenesis,and orlistat blocks fat digestion and absorption in the gut. Several drugs approved for other indications often promote weight loss, including bupropion, metformin, topiramate and zonisamide; they have been used empirically for treatment of obesity and to counter the weight-promoting effects of other medications. Expanding knowledge of the physiological mechanisms of body weight regulation has revealed new molecular targets, and more than 150 novel agents are under active development. Because weight regulation is complex, and redundant systems protect against perceived starvation, optimal treatment of obesity will likely require combinations of therapies. The accelerating emergence of new medications will facilitate the development of such effective combinations.

Similar articles

  • Pharmacologic Therapies for Obesity
    LM Kaplan. Gastroenterol Clin North Am 39 (1), 69-79. PMID 20202580. - Review
    This article examines the transitions in pharmacological therapy for obesity. It reviews the current options approved by the Food and Drug Administration and several drug …
  • Phentermine, Topiramate and Their Combination for the Treatment of Adiposopathy ('Sick Fat') and Metabolic Disease
    H Bays. Expert Rev Cardiovasc Ther 8 (12), 1777-801. PMID 20707765. - Review
    Positive caloric balance often causes pathologic adipocyte and adipose tissue anatomical and functional changes (termed adiposopathy or 'sick fat'), which may lead to pat …
  • Long-term Pharmacotherapy for Obesity
    S Klein. Obes Res 12 Suppl, 163S-6S. PMID 15687412. - Review
    Obese patients unable to achieve significant weight loss with lifestyle changes alone may require drug therapy, and such therapy may be needed long term lest weight lost …
  • Pharmacotherapy of Obesity
    Y Linné et al. Clin Dermatol 22 (4), 319-24. PMID 15475233. - Review
    Whereas several drugs to treat most other chronic conditions have been developed over the last 30 years, progress in pharmacologic therapy for obesity has been slow. The …
  • Pharmacological Treatment of Obesity in Children and Adolescents: Current Status and Perspectives
    N Catoira et al. Expert Opin Pharmacother 11 (18), 2973-83. PMID 20958104. - Review
    The efficacy of these drugs is modest. Our knowledge of their efficacy and safety comes from clinical trials affected by insufficient follow-up (1 year or less); very oft …
See all similar articles

Cited by 22 PubMed Central articles

See all "Cited by" articles

Publication types

MeSH terms

LinkOut - more resources

Feedback